Old Web
English
Sign In
Acemap
>
authorDetail
>
Celine-Lea Halioua-Haubold
Celine-Lea Halioua-Haubold
University of Oxford
Medicine
Choroideremia
Markov model
Nursing
Grey literature
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Brief Overview of Chimeric Antigen Receptor–Mediated Immunotherapy for Glioblastoma Multiforme
2020
Celine-Lea Halioua-Haubold
David Brindley
Show All
Source
Cite
Save
Citations (0)
Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery
2019
BMJ Open
Ching Lam
Edward Meinert
Celine-Lea Halioua-Haubold
Alison Carter
Aidong Yang
David Brindley
Zhanfeng Cui
Show All
Source
Cite
Save
Citations (1)
Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model
2019
Eye
Celine-Lea Halioua-Haubold
Jasleen K. Jolly
James A Smith
Rafael Pinedo-Villanueva
David Brindley
Robert E. MacLaren
Show All
Source
Cite
Save
Citations (4)
A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
2018
Investigative Ophthalmology & Visual Science
Celine-Lea Halioua-Haubold
Jasleen K. Jolly
R Pinedo Villanueva
David Brindley
Robert E. MacLaren
Show All
Source
Cite
Save
Citations (0)
1